title: [Pediatry].
abstract: During the previous year, several changes occurred in paediatric patient's management. The new PALS recommendations redefine the rhythm and the rate between cardiac massage and ventilation as well as the indications for defibrillation. The choice of the test for Helicobacter Pylori depends on the age of the patient and on the clinical situation. New anti-hypertensive drugs allow to limit the progression of chronic renal disease with hyper-tension and/or proteinuria. The choice between immunoglobulins, steroids, splenectomy and rituximab to treat chronic thrombocytopenic purpura treatment is a therapeutic challenge. Finally, a new approach is presented for diagnosis and treatment of iron overload in chronic hemoglobinopathies.
authors.affiliation: Service de pédiatrie, Hôpital de l'enfance, Département médico-chirurgical de pédiatrie, CHUV, Lausanne.
authors.forename: S
authors.initials: S
authors.lastname: Fanconi
authors.forename: M
authors.initials: M
authors.lastname: Gehri
authors.forename: F
authors.initials: F
authors.lastname: Benkebil
authors.forename: A
authors.initials: A
authors.lastname: Nydegger
authors.forename: F
authors.initials: F
authors.lastname: Cachat
authors.forename: G
authors.initials: G
authors.lastname: Zeier
authors.forename: Y D
authors.initials: YD
authors.lastname: Pastore
authors.forename: M
authors.initials: M
authors.lastname: Diezi
mesh_terms: D022561:Advanced Cardiac Life Support / Q000379:methods; D002648:Child; D016481:Helicobacter Infections / Q000175:diagnosis; D016480:Helicobacter pylori; D006453:Hemoglobinopathies / Q000175:diagnosis / Q000188:drug therapy; D006801:Humans; D010372:Pediatrics; D017410:Practice Guidelines as Topic; D016553:Purpura, Thrombocytopenic, Idiopathic / Q000188:drug therapy